Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line-associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic.

ABSTRACT:

Objective

To examine the impact of SARS-CoV-2 infection on CLABSI rate and characterize the patients who developed a CLABSI. We also examined the impact of a CLABSI-reduction quality-improvement project in patients with and without COVID-19.

Design

Retrospective cohort analysis.

Setting

Academic 889-bed tertiary-care teaching hospital in urban Los Angeles.

Patients or participants

Inpatients 18 years and older with CLABSI as defined by the National Healthcare Safety Network (NHSN).

Intervention(s)

CLABSI rate and patient characteristics were analyzed for 2 cohorts during the pandemic era (March 2020-August 2021): COVID-19 CLABSI patients and non-COVID-19 CLABSI patients, based on diagnosis of COVID-19 during admission. Secondary analyses were non-COVID-1

SUBMITTER: Ben-Aderet MA 

PROVIDER: S-EPMC10369209 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature